Aegerion Pharmaceuticals

Aegerion Pharmaceuticals is a private specialty pharmaceutical company focused on developing and commercializing promising therapies to treat cardiovascular and metabolic diseases. The company’s initial focus is on hyperlipidemia. Its most advanced product has demonstrated significant LDL-lowering activity in human trials and is currently in Phase II testing.